SCHEMBL20846874

SCHEMBL20846874

O=c1[nH]cc(C2OCC(O)C(O)C2O)c(=O)[nH]1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.38
▸ DPYD Q12882 4/20 0.34
▸ MAPT P10636 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ ATAD2 Q6PL18 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ CYP19A1 P11511 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ THPO P40225 1/20 0.34
▸ MTOR P42345 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ HBB P68871 1/20 0.34
▸ PMP22 Q01453 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ SLC5A1 P13866 4/20 0.34
▸ SLC5A2 P31639 4/20 0.34
▸ SELL P14151 1/20 0.32
▸ SELP P16109 1/20 0.32
▸ KDM4C Q9H3R0 1/20 0.32
▸ PNP P00491 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18022430 0.73 P2RY2 (0.46) —
SCHEMBL15803217 0.73 PNP (0.44) MAPTLMNATSHRPMP22SMN1; SMN2
SCHEMBL14791302 0.73 PNP (0.44) MAPTLMNATSHRPMP22SMN1; SMN2
SCHEMBL30287919 0.73 PNP (0.44) MAPTLMNATSHRPMP22SMN1; SMN2
SCHEMBL774016 0.73 PNP (0.44) MAPTLMNATSHRPMP22SMN1; SMN2
SCHEMBL64635 0.73 PNP (0.44) MAPTLMNATSHRPMP22SMN1; SMN2
SCHEMBL767777 0.73 PNP (0.44) MAPTLMNATSHRPMP22SMN1; SMN2
SCHEMBL21847661 0.73 PNP (0.44) MAPTLMNATSHRPMP22SMN1; SMN2
SCHEMBL10226283 0.73 PNP (0.44) MAPTLMNATSHRPMP22SMN1; SMN2
SCHEMBL17329460 0.73 PNP (0.44) MAPTLMNATSHRPMP22SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230165815-A1 ROLES OF MODULATORS OF INTERSECTIN-CDC42 SIGNALING IN ALZHEIMER?S DISEASE Lu, Qun (US) 2023-06-01 — — US disclosed
US-20190091184-A1 ROLES OF MODULATORS OF INTERSECTIN-CDC42 SIGNALING IN ALZHEIMER'S DISEASE LU, QUN 2019-03-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230165815-A1 ROLES OF MODULATORS OF INTERSECTIN-CDC42 SIGNALING IN ALZHEIMER?S DISEASE CDC42, MDN1, GAP43 GAA 3174/4885DPYD 2680/4885MAPT 267/4885
US-20190091184-A1 ROLES OF MODULATORS OF INTERSECTIN-CDC42 SIGNALING IN ALZHEIMER'S DISEASE CDC42, MDN1, HASPIN GAA 3203/4885DPYD 2616/4885MAPT 326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback